iThriveMD of Eastlake in Chula Vista operates a LegitScript-certified longevity and medical weight-loss clinic at 970 Eastlake Parkway, part of a multi-location network that has treated over 8,000 patients since launching in 2019. The Eastlake clinic prescribes compounded semaglutide and tirzepatide GLP-1 receptor agonists for weight management alongside testosterone replacement therapy and bioidentical hormone optimization, serving an aesthetic-wellness continuum that includes the injectable services at SDBotox - Chula Vista. In-depth diagnostic panels—including comprehensive metabolic profiles, thyroid function, sex-hormone binding globulin, and inflammatory markers—precede every treatment plan, ensuring pharmacotherapy targets verified biomarker deficiencies. NAD+ intravenous infusion therapy and peptide protocols round out the longevity menu, addressing cellular-level energy production and mitochondrial function through mechanisms also explored in traditional modalities at South Bay Family Acupuncture. The most advanced protocol stacks GLP-1 pharmacotherapy with NAD+ infusion at 250 to 500 milligrams per session, quarterly hormone-panel recalibration, and DEXA-scan body-composition tracking to measure visceral adipose tissue reduction across six-month treatment arcs.